Ancient Romans Ate This Fish to Hallucinate — Scientists Are Now Studying Its Biology

In the natural world, chemistry is often stranger than fiction. Long before modern neuroscience began studying altered states of consciousness, nature had already evolved molecules capable of profoundly changing perception, memory, and sensory processing. One of the most curious examples is the Sarpa salpa, commonly called the dreamfish—a Mediterranean species that has quietly intrigued scientists, historians, and neurologists for centuries.

At first glance, the dreamfish looks surprisingly ordinary. It is a coastal species found throughout the Mediterranean Sea and parts of the eastern Atlantic along Africa’s coastline, typically swimming in large schools over seagrass beds and rocky reefs. The fish has an elongated silver body marked by distinct horizontal golden stripes running from head to tail, making it relatively easy for divers to recognize. Most adults grow to about 30 to 40 centimeters in length, though larger specimens can approach 50 centimeters. Like many reef fish, Sarpa salpa feeds primarily on algae and seaweed.

Yet this ordinary-looking fish carries an extraordinary reputation. Under certain conditions, eating the dreamfish can trigger powerful hallucinations lasting up to 36 hours. Historical accounts suggest that in ancient Rome, the fish was occasionally served at banquets precisely for these mind-altering properties. Today the species remains common in Mediterranean waters, but most people avoid eating it after learning about its unusual neurological effects.

Behind this strange marine anecdote lies something scientifically profound: a window into how natural compounds interact with the human brain. Increasingly, researchers and startups are realizing that the same biological principles seen in the dreamfish may help unlock new treatments for depression, trauma, and neurological disorders.

When the Ocean Becomes a Pharmacology Lab

The hallucinogenic effect associated with Sarpa salpa is believed to originate from toxins that the fish accumulates through its diet, particularly certain species of algae or plankton that produce psychoactive compounds. Because the fish feeds heavily on marine vegetation, these molecules can accumulate in its tissues depending on the season, the ecosystem, and the specific algae present in its habitat.

Scientists believe these compounds may influence serotonin pathways in the brain, which regulate mood, perception, and cognition. Serotonin signaling plays a central role in human consciousness, and many psychiatric medications—from antidepressants to psychedelic compounds—interact with serotonin receptors in order to alter emotional state or sensory processing.

Researchers suspect that compounds associated with dreamfish intoxication may affect 5-HT2A receptors, the same neural targets activated by psychedelic substances such as psilocybin or LSD. When these receptors are activated, they can disrupt normal patterns of neural communication, producing altered sensory experiences and vivid hallucinations.

This phenomenon illustrates a broader biological truth. Evolution has repeatedly produced molecules that interface with animal nervous systems because doing so offers ecological advantages. Plants produce psychoactive chemicals to deter herbivores. Marine organisms generate toxins to protect themselves from predators. Microorganisms synthesize compounds that influence competitors or hosts.

From an evolutionary perspective, the biosphere functions like a vast distributed chemical laboratory, generating millions of molecular experiments over millions of years. Humans are only beginning to rediscover what nature has already built.

Nature’s Advantage in Drug Discovery

Modern pharmaceutical chemistry often attempts to design drugs from scratch, but nature operates differently. Through evolutionary processes, organisms produce molecules that are already biologically active and structurally optimized to interact with living systems. This gives natural compounds several advantages.

Natural molecules frequently possess highly complex three-dimensional structures that synthetic chemistry struggles to invent independently. These structures evolved specifically to bind to biological receptors with precision. As a result, many natural compounds interact with cellular pathways in ways that scientists later adapt into medicines.

Natural compounds also tend to show high selectivity, meaning they affect particular proteins or neural pathways while leaving others relatively untouched. This specificity can reduce unwanted side effects and improve therapeutic outcomes.

Marine ecosystems in particular are emerging as enormous reservoirs of pharmacological potential. Coral reefs, algae, and deep-sea microorganisms produce a vast range of chemical compounds designed to influence biological systems. Many modern drugs—including some cancer therapies and antiviral medications—trace their origins to molecules first discovered in marine organisms.

The dreamfish phenomenon hints that the oceans may still contain countless undiscovered compounds capable of interacting with the human nervous system.

Hallucinations as a Window Into the Brain

The hallucinations associated with Sarpa salpa are not merely biological curiosities. They reveal something fundamental about the brain: perception itself is chemically fragile.

Human sensory experience emerges from electrical and chemical signals moving through billions of neurons. Small changes in neurotransmitter activity can dramatically alter how the brain organizes information from the outside world. Hallucinogenic compounds work by temporarily modifying these signaling systems.

For neuroscientists, such compounds have become valuable tools. By studying how hallucinations occur, researchers gain insight into how the brain constructs perception, memory, and self-awareness.

Recent neuroimaging research has shown that psychedelic compounds can temporarily increase connectivity between brain networks that normally remain separate, particularly between the default mode network and sensory processing regions. This reorganization may explain both the perceptual distortions and the therapeutic effects seen in psychedelic clinical trials.

What once seemed like strange biological accidents—such as hallucinations caused by a Mediterranean fish—may actually reveal important clues about how consciousness itself is organized.

From Ancient Curiosity to Modern Therapeutics

Interest in psychedelic biology has surged dramatically in the past decade. Clinical researchers are now exploring whether compounds that alter perception might help treat depression, PTSD, addiction, and anxiety disorders.

One of the companies at the forefront of this movement is Compass Pathways, a biotechnology startup developing psilocybin-based therapies for treatment-resistant depression.

Instead of ancient Roman banquets, modern psychedelic therapy takes place in carefully controlled clinical environments. Patients receive measured doses of psilocybin while guided by trained therapists in structured sessions designed to facilitate emotional processing and psychological insight.

Early clinical results have been striking. In multiple trials, psilocybin therapy has produced meaningful improvements in patients whose depression had resisted conventional treatments. According to George Goldsmith, “There is a huge unmet need for new treatments in mental health, and psychedelic therapies may offer a fundamentally different approach.”

The key insight is that psychedelic compounds may temporarily loosen rigid neural patterns associated with depression or trauma, allowing the brain to reorganize itself.

In a sense, the same biological principle underlying the dreamfish’s strange effects—natural compounds interacting with neural signaling systems—now forms the foundation of an emerging medical field.

The Marine Frontier of Neurochemistry

While plant-based psychedelics have received much of the recent attention, marine ecosystems may represent an even larger frontier for discovery. The oceans contain an extraordinary diversity of organisms producing chemically sophisticated molecules, many of which evolved specifically to interact with nervous systems.

Marine neurotoxins have already become powerful research tools in neuroscience. Compounds derived from cone snails, for example, have helped scientists understand ion channels that regulate nerve signaling and have inspired medications used to treat severe pain.

It is entirely possible that future discoveries from marine organisms—including compounds related to the dreamfish phenomenon—could inspire entirely new classes of neurological medicines.

In other words, the ocean may still hold chemical solutions to problems we do not yet know how to solve.

The Mystery of the Dreamfish

Despite centuries of anecdotal reports, the exact compound responsible for the dreamfish’s hallucinations remains uncertain. Not every fish triggers the effect. Environmental conditions—including the fish’s diet, geographic location, and the season when it was caught—appear to influence whether psychoactive compounds accumulate in its tissues.

Some scientists suspect that indole alkaloids produced by marine algae may be responsible. Others believe microbial symbiosis in the marine food chain may contribute to the phenomenon. The fact that such a well-known species can still conceal biochemical mysteries highlights how much remains unknown about marine ecosystems.

Even today, nature often hides its most interesting secrets in plain sight.

Lessons From the Dreamfish

The story of Sarpa salpa is more than an unusual culinary warning. It illustrates several deeper truths about science and innovation. Nature has been conducting biochemical experimentation for billions of years, generating molecules capable of interacting with human biology in subtle and powerful ways.

Many of these compounds remain undiscovered, particularly in marine ecosystems that scientists have barely explored. At the same time, modern biotechnology is beginning to translate natural discoveries into therapeutic applications.

Companies like Compass Pathways represent only the early stages of a broader movement toward nature-inspired neuropharmacology, where ancient biology and modern medicine intersect.

The dreamfish reminds us that long before laboratories and venture capital, the natural world was already inventing molecules capable of reshaping human consciousness. Sometimes innovation begins not in a research lab, but in the quiet chemistry of the sea.